Barrons
Goldman Pharma View: Buy AGN, Sell FRX, MRX A Takeover Target
A recent selloff in specialty pharmaceuticals has creating a buying opportunity, according to Goldman Sachs analyst Gregory Waterman, but he thinks investors should be discriminating. Allergan (AGN) is his top pick, a best-in-breed name that’s at a nice entry point. “Mid-teens EPS growth remains scarce in healthcare and AGN is structurally well positioned given: (1) [...]
|
Nikkei
Santen Pharma Hit '12 Low On FY12 Profit Fall Outlook |
Hindustan Times
Highly volatile rupee turns minefield for pharma firms
The rupee's depreciation is on paper a good thing for the export-oriented pharmaceutical firms that can get more for the dollars they earn, but the industry as a whole is worried because the volatility in the currency is a bigger concern for drug manufacturers who can get their import numbers wrong.
|
The Nation
Govt urged to rationalise taxes on pharma sector
ISLAMABAD - The multinational pharmaceutical companies have proposed the government to rationalise taxes imposed on the sector in the upcoming budget, as the existing pricing mechanism in Pakistan is a major hurdle in the way of attracting foreign investment in the country and some multinational companies have even closed their operations in Pakistan during the past five years.
The ...
|
FT
Global pharma: time to do drugs
In theory, pharma stocks are poised for a rally, especially given that most of the groups have sub-market valuations
|
APA-OTS
Richter Pharma erweitert seine Schmerzkompetenz - BILD
Utl.: Der Umsatz konnte in 2011 deutlich auf 317,7 Mio Euro
gesteigert werden. Investiert wird nun in den Ausbau der
Produktion von Veterinärarzneimitteln am Standort Wels. =
Wels (OTS) - Erneut konnte die Welser Richter Pharma im
vergangenen Geschäftsjahr 2011 ein deutliches …
|
APA-OTS
Kwizda Pharma präsentiert das neue ATEIA(R) SUNPROTECT PLUS REPAIR
Utl.: Die patentierte Formel für Sonne ohne Reue =
Wien (OTS) - Mit einem gemäß den Marktbedürfnissen optimalen
Produktsortiment, neuem Verpackungsdesign und der patentierten
Wirkstoff-Formel eröffnet ATEIA(R) eine neue Ära im dermatologischen
Sonnenschutz.
Zwtl.: Optimierter Schutz …
|
FT
AstraZeneca among suitors eyeing Amylin
Move comes amid flurry of pharma M&A activity as analysts value US drugmaker at about $3.5bn, with first-round bids expected in next two weeks
|
Mail & Guardian
Section27 joins big pharma bust-up
The TAC has joined the fray in a face-off between Aventis Pharma and Cipla Life Sciences in a patent dispute over the cancer drug, Docetaxel.
|
manager magazin
Pharmakonzern: Merck will bei Serono kräftig sparen
Der Pharma- und Spezialchemiekonzern Merck hat zum Jahresauftakt einen Gewinneinbruch verzeichnet und zieht Konsequenzen. Ab 2014 will das Unternehmen bei der Pharmatochter Serono 300 Millionen Euro pro Jahr einsparen - und gleichzeitig kräftig verdienen.
|
FTD
Problemtochter Serono: Merck erleidet herben Gewinneinbruch
Mit dem Merck-Börsenpapier geht es bergab: Das strauchelnde Chemiegeschäft setzt dem Pharma- und Spezialchemiekonzern zu Jahresbeginn zu und verunsichert Anleger. Die Hoffnungen ruhen auf dem massiven Sparprogramm.
|
ARD
Merck verbucht Gewinneinbruch
Der Pharma- und Chemiekonzern hat im ersten Quartal wegen eines Umsatzrückgangs im Chemiegeschäft weniger verdient. Der Dax-Konzern wird derzeit umgebaut und will sparen. Die Aktie gibt nach.
|
Handelsblatt
Pharmakonzern: Gewinn von Merck bricht ein
Massiver Gewinneinbruch bei Merck: Der Pharma- und Chemiekonzern hat zum Jahresauftakt fast 50 Prozent weniger Überschuss erzielt. In diesem Jahr konzentriert sich Merck vor allem aus sein Sparprogramm.
|
DieZeit
Pharma: Celesio schreibt rote Zahlen
Stuttgart (dpa) - Der kränkelnde Pharmagroßhändler Celesio ist mit seinem breit angelegten Umbau in die roten Zahlen gerauscht.
Vor allem hohe Abschreibungen auf die kürzlich zum Verkauf geste...
|
Eurosport
Cyclisme - Tour de Californie - Horner veut remettre ça
L'Américain Chris Horner (RadioShack) défend à partir de dimanche son titre dans le 7e Tour de Californie, et ne devrait pas avoir à se soucier de son compatriote Levi Leipheimer (Omega Pharma), triple vainqueur de l'épreuve mais diminué par une blessure.
|
ElPais
Rubiano se luce en la sexta etapa
El ciclista colombiano se despegó del grupo de escapados a 35 kilómetros de la meta. -Malori nueva 'maglia' rosa
|
siliconindia
Hiring Activities Improved in April, Says Report
In signs of better job market prospects, hiring activities increased across many sectors, including banking and pharma in April, says a survey by leading employment portal Naukri.com.
|
MarketWatch
Arena Pharma shares resume trading, jump 89%
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
|
Technology Review
The Future of Pharma is Incredibly Fast
Continuous manufacturing will transform the drugs are made, says Novartis president.
At the second day of a manufacturing conference on MIT’s campus, the CEO of pharmaceutical giant Novartis, Joseph Jimenez, suggested big changes are in store for the way his company makes drugs. A new, experimental method for producing pills could drastically reduce production times, increase revenue, and impro...
|
Times of India
Pharma companies targeting small towns for drug trials
While pharma companies have claimed that most of their drug trials were taking place in “cosmopolitan towns” the House panel on health has found it incorrect.
|
Times of India
Pharmaceutical companies targeting smaller cities for drug trials
While pharma companies have claimed that most of their drug trials were taking place in “cosmopolitan towns” the House panel on health has found it incorrect.
|
science blogs
The (not so) Thinking Moms' (D)evolution's Declaration [Respectful Insolence]
One of the most inaptly named groups I've ever seen is called Thinking Moms' Revolution (henceforth abbreviated as TMR). Given the reality of what TMR really is, the word "thinking" applied to TMR is, as they say, so wrong it's not even wrong. As for a "revolution," what TMR really represents is nothing revolutionary at all, unless you consider antivaccinationism, run-of-the-mill antiscience pa...
|
Times of India
Cipla may cut prices of other cancer drugs too
Domestic pharma major Cipla may extend its "affordable and humanitarian" pricing strategy on other anti-cancer drugs in its portfolio, even as domestic generic companies are still trying to grapple with the huge cuts and evaluate their pricing options.
|
Technology Review
Shelved Drugs Become a New Research Resource
The National Center for Advancing Translational Sciences, which is the newest branch of the National Institutes of Health, is partnering with big pharma to give academic researchers access to more than 20 drugs that have passed some safety testing in humans but for some reason have been iced by the drug makers.
|
Reuters
U.S. to partner with Big Pharma for drug discovery
CHICAGO (Reuters) - The U.S. government will help drug companies find treatments for a host of diseases through a new collaboration in which researchers at the National Institutes of Health will test experimental drugs provided by manufacturers.
|
Reuters
TEXT-Fitch: Rating headroom for European big pharma, such as Novartis, to execute acquisitions
May 03 - Fitch Ratings says the big Fitch-rated European pharmaceuticals companies, such as
Novartis (rated 'AA'), have headroom within their current ratings to pursue bolt-on
or even larger...
|
Zeit
Pharma: Pfizer leidet unter Nachahmer-Präparaten
<img style="float:left; margin-right:5px" src="http://images.zeit.de/news/../publishedPictures/Pfizer_36326534_onlineBild.jpg-148x84.jpg"/>New York (dpa) - Der US-Pharmariese Pfizer kämpft weiterhin mit rückläufigen Geschäften. Im ersten Quartal fiel der Umsatz um 7 Prozent auf 15,4 Milliarden Dollar (11,7 Mrd Euro).
Der Gewinn b...
|
Telegraph
Questor share tip: GlaxoSmithKline remains the pharma to own
Last week's first-quarter results from pharmaceuticals group GlaxoSmithKline were below market expectations. However, there are no changes to full-year guidance.
|
lesoir
20:07 Tour de Turquie : le Belge Iljo Keisse s’impose
Le Belge Iljo Keisse (Omega Pharma) a remporté samedi la 7e étape du Tour de Turquie cycliste disputée sur 124 km entre Kusadasi et Izmir (ouest) alors que le Bulgare Ivaïlo G...lire la suitehistoires liées20:08 Ben Laden : le Pakistan dit avoir renseigné les USA20:06 Tennis : une finale Nadal – Ferrer à Barcelone20:10 Foot : Hazard repris pour jouer contre le PSG20:09 Foot : 16 joueurs de Leir...
|
Irish Times
Jazz could pay €530m for US pharma
DUBLIN-BASED Jazz Pharmaceuticals has agreed to pay up to $700 million (€530 million) in cash for a speciality drug business in the US that has recently been granted approval for a new drug targeting childhood leukaemia.
|
lesoir
Omega Pharma lève 300 millions d’euros en un jour
Omega Pharma a levé le montant maximum de 300 millions d’euros lors du premier jour de sa souscription, a fait savoir l’entreprise ce jeudi. L’opération est donc cl...lire la suite
|
manager magazin
Umsatzplus: Agrarchemie beflügelt Bayer
Dank des guten Geschäfts mit Agrarchemie hat Bayer im ersten Quartal mehr verdient als erwartet. Der Leverkusener Pharma- und Chemieriese bestätigte die Jahresprognose - Analysten rechnen möglicherweise mit einer Anhebung.
|
Irish Times
Amgen to buy Turkish pharma firm
US biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers' thirst for emerging markets sales.
|
Reuters
India's Intas Pharma says to raise 3 bln rupees from ChrysCapital
MUMBAI, April 25 (Reuters) - Indian drugmaker Intas
Pharmaceuticals said on Wednesday that it is raising three
billion rupees ($57 million) from private equity firm
ChrysCapital ahead of its public...
|
WirtschaftsWoche
Pharma: Keine Genesung am Generika-Markt
Die günstigen Imitate von Markenmedikamenten drücken den Gewinn von forschenden Pharmaherstellern. Und durch wachsende Konkurrenz machen sich die Hersteller sogenannter Generika auch gegenseitig zu schaffen.
|
Times of India
Domestic pharma market posts double-digit growth in March
The domestic pharma retail market posted a high growth of nearly 22% growth for March, the highest in the last 18 months.
|
THE GLOBE AND MAIL
AstraZeneca poised to buy biotech Ardea for $1.3-billion
Deal underscores Big Pharma appetite for biotech assets
|
Zeit
Aktionärsprotest: In der Bayer-Bilanz schlummert ein unbekanntes Risiko
Der Pharma- und Chemiekonzern wird in den USA massenhaft wegen einer Antibabypille verklagt. Das kann das Unternehmen teuer kommen. Von Jahel Mielke
|
TheDomains
MarkMonitor To Offer A Free “New gTLD Application Database”
According to a email we just received, the brand protection domain registrar MarkMonitor.com will be releasing a “New gTLD Application Database” which allow users to quickly search all data provided by ICANN (after the Big Reveal) (using wildcards):
gTLD String
Mission and Purpose
Applicant Name
Registry Website
Primary and Secondary Contact Names and Email Addresses
Application Type (Community...
|
THE GLOBE AND MAIL
Valeant buys Mexican generic drugmaker's assets
Valeant said it will buy certain assets from Atlantis Pharma, a branded generic pharmaceutical company, for about $71 million, to expand its footprint in Mexico.
|
Le Point
BioAlliance Pharma: lourde perte en 2011, mais trésorerie en hausse
La société française de biotechnologies BioAlliance Pharma a annoncé mardi...
|
APA-OTS
IQPC präsentiert Cold Chain IQ, das internationale Ressourcenzentrum für Temperaturüberwachungsprofis, in neuer Form
London (ots/PRNewswire) -
ColdChainIQ.com, das Online-Netzwerk und Content-Forum für
Temperaturüberwachung für die Biobranche, wurde in brandneuem Design
und Struktur wieder auf den Markt gebracht.
ColdChainIQ.com bietet der Pharma- und der Biotechlieferkette
kostenlosen Zugang zu …
|
Eurosport
Cyclisme - Martin accidenté à l'entrainement
Tony Martin, le champion du monde du contre-la-montre, a été victime d'un accident ce jeudi. L'Allemand a été percuté par une voiture à l'entrainement. Le rouleur d'Omega Pharma Lotto a été transporté inconscient à l'hôpital et souffre de fractures à la mâchoire et à la pommette.
|
AP
Takeda to buy URL Pharma for $800M upfront
Japanese drugmaker Takeda Pharmaceutical Co. Ltd. said Wednesday it will pay $800 million upfront to buy the privately held U.S. gout treatment maker URL Pharma Inc....
|
Les Echos
Takeda rachète URL Pharma pour 800 millions de dollars
[[384910]] Takeda Pharmaceutical a annoncé mercredi l'achat pour 800 millions de dollars (609 millions d'euros) d'URL Pharma, un laboratoire américain spécialisé dans le traitement de la goutte. Le premier groupe pharmaceutique japonais versera en outre un complément en fonction des performances...
|
Le Point
Paris-Roubaix: quatrième victoire du Belge Tom Boonen
Le Belge Tom Boonen (Omega Pharma) a remporté dimanche pour la quatrième...
|
L'EQUIPE
Cyclisme - Roubaix - Boonen au paradis
Tom Boonen (Omega Pharma - Quick Step) remporte Paris-Roubaix pour la...
|
WSJ
No Miracle Cure in Pharma M&A
Drug companies have growing pains. But getting out their checkbooks to make up $35 billion in lost revenue from patent expirations is an expensive strategy.
|
WSJ
No Miracle Cure in Pharma M&A
Drug companies have growing pains. But getting out their checkbooks to make up $35 billion in lost revenue from patent expirations this year is an expensive strategy.
|
NZZ
Die Rekombination zweier Branchen
Die Pharma- und die Biotechindustrie haben sich angenähert
|
Huffington Post
Mirabegron, Overactive Bladder Drug, Works But Liver And Heart Concerns Raised
WASHINGTON, April 3 (Reuters) - U.S. drugs reviewers said Astellas Pharma Inc's treatment for an overactive bladder worked, but raised concerns about liver and heart safety issues. The U.S. Food and Drug Administration staff said the once-daily tablet, called mirabegron, worked to reduce frequent urination and the inability to control it, according to documents released onl...
|
science blogs
Kommentar von Karl Benz bei "Chlorbleiche trinken ist ungesund!" (Mutterwitz) am 02.04.2012
Von wegen Chlorbleiche.
Das Endprodukt ist nach 9 Stunden der Aktivierung wird zu Speisesalz in winzigen Milligrammbereich im Körper. Nichts bleibt übrig von dem Gas Chlordioxid . Die Dosis ist entscheidend und nicht ob das "Gift " in großen Mengen tödlich ist . Die pharmazeutischen Giftmedikamente lassen Spuren im Körper zurück mit Nebelwirkungen aber nicht das MMS das exakt dosiert werden kan...
|
physorg
Inside a plant's pharma factory
A newly discovered enzyme brings scientists one step closer to understanding how plants manufacture a molecule with potent medicinal properties.
|
Orf
Mikroalgen für die Kosmetik
Grazer Forscher untersuchen das vielfältige Potenzial von Mikroalgen für den Pharma- und Kosmetikbereich.
|
THE GLOBE AND MAIL
Drug companies watching India's drug patent case
Top court ruling on dispute between pharma giant Novartis and government will have major impact on countrys booming generic industry
|
lesoir
Tom Boonen remporte le GP de l’E3
Tom Boonen (Omega Pharma) a remporté pour la cinquième fois de sa carrière le Grand Prix de l’E3 en devançant au sprint l’Espagnol Oscar Freire et l’Autrichi...lire la suite
|
L'EQUIPE
Cyclisme - GP E3 - Au tour de Chavanel
Depuis le début de la saison, l'équipe d'Omega Pharma - Quick Step...
|
THE AUSTRALIAN
Sigma Pharma back in black
SIGMA Pharmaceuticals said that it returned to profit in fiscal 2011, following two years of losses.
|
TechCrunch
Index Launches Its First Life Sciences Fund: $200M And Partnering With Glaxo and Johnson & Johnson
Index Ventures may be best known on these pages for its technology investments, but today it launched a new fund that points to how the company is willing to put its money into other examples of strong innovation. The life sciences fund will see Index put in $100 million of its own capital, and have it matched by $50 million each from big pharma leaders GlaxoSmithKline and Johnson & Johnson...
|
Slashdot
Indian Gov't Uses Special Powers To Slash Cancer Drug Price By 97%
suraj.sun sends this quote from the Times of India:
"In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licensing approval, t...
|
Les Echos
Recherche contre le cancer: 2,6 milliards de dollars pour une start up américaine
[[370286]] NEW YORK (AFP) : Le groupe pharmaceutique japonais Dainippon Sumitomo Pharma (DSP) s'est dit prêt à dépenser jusqu'à 2,6 milliards de dollars pour racheter, en plusieurs étapes, la "start up" américaine Boston Biomedical, spécialisée dans les traitements contre le cancer. DSP, filiale...
|
siliconindia
75:25 , a confusing judgement
by Vasudevan Vasudevan 75:25, a confusing judgement
I am no fan of Baba Ramdev. Trained as a pharmacist, I oppose anyone claiming cures just from ancient texts for mitigation of as yet incurable diseases, may be to be gulped with the uttering of a Sanskrit sloka to enhance the effect, while modern science is struggling hard to find cures for intractable maladies at the expense of mil...
|
WSJ
Brazil Pharma comprará a su rival Sant'ana
La firma minorista farmacéutica Brazil Pharma SA anunció su segunda adquisición en menos de cuatro meses, en el marco de sus planes de expansión anunciados cuando realizó una oferta pública inicial.
|
The Nation
Punjab govt for putting pharma directors on ECL
LAHORE – Punjab government in its report has requested Supreme Court of Pakistan to put names of Directors of Afroz Chemical on Exit Control List (ECL) so that they could not travel abroad, Sources in Punjab government revealed on Monday. It is worth mentioning that the medicines manufactured by their company caused more than 100 deaths in the province. Names of four directors were ...
|
The Nation
Punjab govt for putting pharma directors on ECL
LAHORE – Punjab government in its report has requested Supreme Court of Pakistan to put names of Directors of Afroz Chemical on Exit Control List (ECL) so that they could not travel abroad, Sources in Punjab government revealed on Monday. It is worth mentioning that the medicines manufactured by their company caused more than 100 deaths in the province. Names of four directors were ...
|
The Nation
Punjab govt for putting pharma directors on ECL
LAHORE – Punjab government in its report has requested Supreme Court of Pakistan to put names of Directors of Afroz Chemical on Exit Control List (ECL) so that they could not travel abroad, Sources in Punjab government revealed on Monday. It is worth mentioning that the medicines manufactured by their company caused more than 100 deaths in the province. Names of four directors were ...
|
Huffington Post
Adam Wolfberg, M.D.: Progesterone: The Oldest "New" Drug to Nearly Reach the Market
There is a certain comfort that comes from prescribing an approved drug for its FDA-indicated purpose. However, the most exciting news in preterm birth prevention resulted from two studies published in 2003 using compounded progesterone. Since then, the involvement of Pharma and the FDA seems only to have undermined patient care.
|
China Daily
Pharma and medical exports likely to surge
The growth of imports and exports of Chinese-made medicines almost doubled the growth rate of the nation's total foreign trading volume as a whole during the first 11 months of last year.
|
Reuters
Pharma pays up for scarce assets
SAN FRANCISCO (Reuters) - When it comes to healthcare deals, the new motto may be "too expensive to fail."
|
Washington Post
FDA warns of pill mix-up with powerful painkiller drugs from Endo Pharma, though risks are low
WASHINGTON — The Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain drugs and common over-the-counter medications made at a Novartis manufacturing plant.
The issue stems from manufacturing problems at a Lincoln, Neb., facility which triggered a recall Sunday of 1,645 lots of Novartis’ over-the-counter drugs, including Excedrin, Bufferin,...
|
Reuters
Omega Pharma CEO succeeds with takeover
BRUSSELS (Reuters) - Omega Pharma said on Tuesday its founder and Chief Executive Marc Coucke had succeeded with his $1.1 billion takeover of the Belgian health products distributor.
|
Irish Times
Brammeier set to make early debut
CYCLING:IRISH ROAD race and time-trial champion Matt Brammeier is set to get his season off to an early start, making his debut with his new Omega Pharma Quick Step team in less than a month’s time. The former HTC Highroad rider will line out as part of the squad in the Santos Tour Down Under, the first UCI World Tour race of the season.
|
Barrons
Watson Pharma Wins Big With Amgen Pact
Watson was not likely to become a major biosimilars player on its own.
|
Barrons
Pro-Active Pfizer
The No.1 pharma company has made smart deals with vendors. In addition to sprucing up its payout, Pfizer is buying back shares. And share price is up a healthy measure from its year-ago level.
|
FOCUS
Statt Tierversuch - Haut züchten aus der Penis-Vorhaut
Aus der Vorhaut von kleinen Jungen entwickelt eine Maschine vollautomatisch künstliche Haut zu Testzwecken für die Pharma- und Kosmetikindustrie. Die Hautfabrik ist eine Erfindung des Fraunhofer-Instituts. Mit ihr wollen die Forscher auch Tierleben retten.
|
APA-OTS
EANS-News: SYGNIS Pharma AG / SYGNIS gibt Ergebnisse ihrer Phase-II-Studie mit AX200 in akutem ischämischem Schlaganfall bekannt =
--------------------------------------------------------------------------------
Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der
Emittent/Meldungsgeber verantwortlich.
--------------------------------------------------------------------------------
Heidelberg (euro ...
|
Irish Times
Pharma giant plans to expand in Cork
PHARMACEUTICAL giant Eli Lilly has plans to build a 22,000sq m facility at its Co Cork plant.
|
Daily Mail
Prime Minister's bazooka for UK healthcare - but he needs to do more
JULIA MANNING: David Cameron was a surprise guest at the Financial Times Biotech and Pharma Conference today, finally acknowledging how 'the Life Sciences sector is a jewel in the crown of our economy'.
|
BoingBoing
Congressional SOPA hearings: no opponents of the bill allowed
As the House of Representatives opens hearings on SOPA, the worst piece of Internet legislation in American history, it has rejected all submissions and testimony from public interest groups and others who oppose the bill. Irony Alert: The House is holding hearings on sweeping Internet censorship legislation this week -- and it's censoring the opposition! [...]
|
WirtschaftsWoche
Pharmahersteller: Stada kauft Generika-Geschäft in der Schweiz
Der Pharmahersteller Stada übernimmt für 78 Millionen Euro Teile der Spirig Pharma AG. Der Zukauft umfasst insgesamt 71 Präparate, die weiter unter der Spirig-Marke vertrieben werden dürfen.
|
Nature
Drug research feels Europe's pain
Pharma companies see drops in revenue amid European austerity measures.
|
# |
Countries |
MIX |
| 1 | India | 40.015 |
| 2 | United States | 5.399 |
| 3 | Turkey | 4.690 |
| 4 | Germany | 1.165 |
| 5 | Japan | 1.057 |
| 6 | France | 0.765 |
| 7 | Switzerland | 0.530 |
| 8 | Canada | 0.420 |
| 9 | Austria | 0.410 |
| 10 | United Kingdom | 0.390 |
| 11 | Romania | 0.350 |
| 12 | Philipines | 0.290 |
| 13 | Belgium | 0.240 |
| 14 | Italy | 0.160 |
| 15 | Norway | 0.160 |
| 16 | Denmark | 0.150 |
| 17 | Indonesia | 0.100 |
| 18 | Finland | 0.080 |
| 19 | Netherlands | 0.075 |
| 20 | Mexico | 0.050 |
| More Countries >> |
# |
Media |
MIX |
| 1 | Dainik Bhaskar | 21.200 |
| 2 | Dainik Jagran | 6.600 |
| 3 | IBN live | 2.000 |
| 4 | Navbharat Times | 2.000 |
| 5 | Prabhat Khabar | 1.940 |
| 6 | economictimes | 1.320 |
| 7 | milliyet.com.tr | 1.200 |
| 8 | ntv msnbc | 1.200 |
| 9 | CNN turk | 1.000 |
| 10 | NDTV profit | 1.000 |
| 11 | Asahi Shimbun | 0.800 |
| 12 | Nature | 0.800 |
| 13 | bbc Hindi | 0.700 |
| 14 | Times of India | 0.600 |
| 15 | Forbes | 0.520 |
| 16 | CNBC | 0.500 |
| 17 | focus.de | 0.480 |
| 18 | Yahoo India | 0.480 |
| 19 | drugs.com | 0.450 |
| 20 | AARP Bulletin | 0.450 |
| More Media >> |
# |
Languages |
MIX |
| 1 | Hindi | 32.440 |
| 2 | English | 14.074 |
| 3 | Turkish | 4.690 |
| 4 | German | 2.105 |
| 5 | Japanese | 1.057 |
| 6 | French | 0.965 |
| 7 | Romanian | 0.350 |
| 8 | Italian | 0.160 |
| 9 | Norwegian | 0.160 |
| 10 | Danish | 0.150 |
| 11 | Dutch | 0.115 |
| 12 | Indonesian | 0.100 |
| 13 | Spanish | 0.090 |
| 14 | Finnish | 0.080 |
| 15 | Polish | 0.040 |
| 16 | Chinese | 0.000 |
| 17 | Korean | 0.000 |
| 18 | Arabic | 0.000 |
| 19 | Portuguese | 0.000 |
| 20 | Swedish | 0.000 |
| More Languages >> |
# |
Lists |
| 1 | Micro Economic words |
| 2 | General Terms |